[Skip to Content]
[Skip to Content Landing]
August 29, 1914


JAMA. 1914;LXIII(9):785-786. doi:10.1001/jama.1914.02570090071023

The noted advance in therapeutics shown in the development of vaccine therapy has brought with it grave dangers as well as advantages. We have, on a number of occasions, discussed in special articles and in editorials the dangers which threatened from the rapid commercialization of this new method. The unscientific character of mixed vaccines and of the mixed filtered products of a number of vaccines marketed as "Phylacogens" has been especially emphasized and the danger from their indiscriminate use pointed out. A little over a year ago we published a series of articles dealing with the whole subject in which the nature of mixed vaccines was described1 as follows:

The mixed stock vaccine of commerce is a makeshift. It is offered as a substitute for correct diagnosis. Like all such makeshifts in science, it is doomed to failure.... A burden is being forced on the profession which

First Page Preview View Large
First page PDF preview
First page PDF preview